Imitrex Tablets Formulated with Rt Technologytm

succinate) was the first triptan medication to target the nerves and blood vessels believed to trigger a total migraine (including throbbing pain, nausea, and sensitivity to light and sound, with or without aura). The first triptan to receive Food and Drug Administration (FDA) approval for the acute treatment of migraines in adults, IMITREX has treated more than 750 million migraines in the past decade. IMITREX Tablets formulated with RT Technology offer significantly faster dissolution and absorption after swallowing in the crucial first two hours after the onset of migraine symptoms compared with conventional IMITREX Tablets. Just as with conventional IMITREX Tablets, IMITREX Tablets with RT Technology can be swallowed whole at the first sign of headache pain for effective migraine relief without drowsiness. Introduced in 2004, IMITREX Tablets with RT Technology are bioequivalent to conventional IMITREX Tablets as measured by AUC0 to 24 and Cmax. 2,3